• Molecular NamePentosan Polysulfate
  • SynonymNA
  • Weight602.497
  • Drugbank_IDDB00686
  • ACS_NO37300-21-3
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-14.15
  • pkaN/A
  • LogD (pH=7, predicted)-21.15
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.22
  • LogSw (predicted, AB/LogsW2.0)585383.0
  • Sw (mg/ml) (predicted, ACD/Labs)1000.0
  • No.of HBond Donors6
  • No.of HBond Acceptors21
  • No.of Rotatable Bonds10
  • TPSA356.07
  • StatusFDA approved
  • AdministrationOral, intramuscular, intra-articular, intraventricular
  • PharmacologyThe first oral medication approved by the U.S. FDA for the treatment of interstitial cystitis, also known as painful bladder syndrome.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability3.0
  • Protein binding3.4
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life4.8 h
  • ExcretionUrine
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A